These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8811381)

  • 1. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study.
    Soslow RA; Chung MH; Rouse RV; Hendrickson MR; Longacre TA
    Int J Gynecol Pathol; 1996 Jul; 15(3):209-16. PubMed ID: 8811381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics.
    Bui CM; Azimpouran M; Balzer B; Maluf H; Medeiros F
    Int J Gynecol Pathol; 2024 Nov; 43(6):586-594. PubMed ID: 38833724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
    Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
    Worrell HI; Sciallis AP; Skala SL
    Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases.
    Longacre TA; Chung MH; Rouse RV; Hendrickson MR
    Am J Surg Pathol; 1996 Jan; 20(1):1-20. PubMed ID: 8540600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion-targeted cytology to improve cytological sampling for atypical polypoid adenomyomas of the uterus: A case series and review of the literature.
    Omori M; Kawai M; Ogawa T; Sasatsu S; Fukasawa H; Nakazawa K; Kondo T; Hirata S
    Cytopathology; 2020 Nov; 31(6):579-585. PubMed ID: 32779225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features.
    Lu B; Yu M; Shi H; Chen Q
    Pathol Res Pract; 2019 Apr; 215(4):766-771. PubMed ID: 30661903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
    Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
    Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistent atypical polypoid adenomyoma and endometrial adenocarcinoma.
    Mittal KR; Peng XC; Wallach RC; Demopoulos RI
    Hum Pathol; 1995 May; 26(5):574-6. PubMed ID: 7750942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
    Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
    Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical polypoid adenomyoma of the uterus: an immunohistochemical study on 5 cases.
    Terada T
    Ann Diagn Pathol; 2011 Oct; 15(5):338-41. PubMed ID: 21684185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
    Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent atypical polypoid adenomyoma and complex atypical endometrial hyperplasia in the uterus.
    Horita A; Kurata A; Komatsu K; Yajima M; Sakamoto A
    Diagn Cytopathol; 2010 Jul; 38(7):527-32. PubMed ID: 19950396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple atypical polypoid adenomyoma of the uterus.
    Horikawa M; Shinmoto H; Soga S; Shiomi E; Sei K; Shimazaki H; Kaji T
    Jpn J Radiol; 2012 Aug; 30(7):606-11. PubMed ID: 22684616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
    Aggarwal N; Bhargava R; Elishaev E
    Int J Gynecol Pathol; 2012 Sep; 31(5):447-52. PubMed ID: 22833085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
    Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
    Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of stromal markers in atypical polypoid adenomyoma.
    Travaglino A; Raffone A; Gencarelli A; Zullo F; Di Spiezio Sardo A; Insabato L
    Pathol Res Pract; 2020 Nov; 216(11):153133. PubMed ID: 32823231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of atypical polypoid adenomyoma.
    Yamashita Y; Torashima M; Hatanaka Y; Takahashi M; Fukumatsu K; Tanaka N; Miyazaki K; Okamura H
    Comput Med Imaging Graph; 1995; 19(4):351-5. PubMed ID: 8653672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Menorrhagia as a consequence of atypical polypoid adenomyoma in uterus].
    Foss Hansen MF; Marcussen Skovby BD
    Ugeskr Laeger; 2012 May; 174(21):1464-5. PubMed ID: 22640791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.